Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AB, accrual, acknowledged, agreed, appointment, Bayh, beneficiary, cast, cease, consideration, counsel, created, directly, disruption, event, fiscal, foreseeable, formulae, independent, indirectly, influencing, intention, intercompany, judging, largest, leasehold, LLC, LLP, Milano, monetary, multiple, open, owner, passive, Pharmacia, proportion, prospectively, ratified, receipt, reliance, Sacane, satisfied, Schedule, Scott, settlement, subsidiary, Susan, trading, undue, variable, volume
Removed:
authorized, borrow, Certification, certifying, check, dated, duly, Employer, equivalent, furniture, Identification, incorporation, INDEX, IRS, laboratory, law, licensed, mark, Mayleben, meet, party, past, pharmaceutical, preceding, Qualitative, Quantitative, registrant, rely, Senior, shorter, significantly, state, STREET, subcaption, Submission, Supplemental, thereunto, Timothy, undersigned, Vote, Washington
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.55 EX-10.55 Advisory Services Agreement
- 10.56 EX-10.56 Employment Agreement - Adeoye Y. Olukotun
- 10.57 EX-10.57 Amend. No. 1 to 2000 Equity Compensation
- 10.58 EX-10.58 Office Lease - State 94 Properties, LLC
- 31.1 EX-31.1 Certification Pursuant to Rules 13A-14(A)
- 31.2 EX-31.2 Certification Pursuant to Rules 13A-14(A)
- 32.1 EX-32.1 Certification Pursuant to 18 Usc Sec. 1350
- 32.2 EX-32.2 Certification Pursuant to 18 Usc Sec. 1350
Esperion Therapeutics similar filings
Filing view
External links
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 BY THE CHIEF EXECUTIVE OFFICER
RELATING TO A PERIODIC REPORT CONTAINING FINANCIAL STATEMENTS
I, Roger S. Newton, Chief Executive Officer, of Esperion Therapeutics, Inc., a Delaware corporation (the “Company”), hereby certify that:
(1) The Company’s periodic report on Form 10-Q for the period ended June 30, 2003 (the “Form 10-Q”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
* * *
/s/ Roger S. Newton Roger S. Newton, Chief Executive Officer |
Date: August 14, 2003